Episurf Medical AB B EPIS B - Köp aktien på Nasdaq

Episurf Medical AB EPIS-B : STO Stock Price & News - Google

There are two types of shares in the company. The total number of shares outstanding is 222,040,543, of which 971,024 are Class A-shares and 221,069,519 are Class B-shares. Episurf Medical was founded in 2009 and develops and commercialises patient-specific medical devices for the treatment of painful joint injuries. Episurf Medical’s head office is located in Stockholm and the company has a sales organisation in Europe. The share (EPIS B) is listed on Nasdaq Stockholm.

Johannes Holz från Orthocentrum, Park-Klinik Manhagen, Hamburg, Tyskland, et al., vilken presenterades vid 3rd World Arthroplasty Congress, nu är tillgänglig via Episurf Medicals hemsida. New Swedish patent approval for Episurf Medical (Cision) 2020-06-22 17:45 The patent, entitled “An implant for cartilage and/or bone repair” , is within the area of joint implant materials and implant features. News feed of Episurf Medical. Episurf Medical är ett verksamma inom medicinteknik.

AnalysisNews. The best share price.

Nytt aktiekapital och antal aktier i Episurf Medical

Medicinteknikbolaget Episurf Medical har genomfört en riktad nyemission som tillför det 66,3 miljoner kronor före transaktionskostnader. XACT - Cision News; BRIC-länderna faller - SKAGEN Fonder September börsen; Spela spelet, övertro till tekniken och utskälld i affär 23. Back to News. 2018.05.14.

Episurf Medical AB Skatteverket

New US patent approval for Episurf Medical. Publicerad: 2021-01-27 (Cision) Nytt patentbeviljande i USA för Episurf Medical. Publicerad: 2021-01-27 (Cision) Tisdag Presentation från Episurf Medical Capital Markets Day, Stockholm, 15 september 2020 . Under kapitalmarknadsdagen presenterade Episurfs ledningsgrupp, nyckelkunder och samarbetspartners olika delar av verksamheten.

Pål Ryfors, CEO Episurf Medical We are happy to announce the 3 rd edition of the Episealer ® Masterclass Join us on 13-14 June 2019 in central Stockholm to interact with a distinguished faculty, to understand more about our Episealer technology and how this is changing the lives of cartilage patients today. Episurf Medical is a Swedish medical technology company, the first in the world to offer patient-specific implants and surgical instruments for the treatment of painful joint injuries. By combining expertise in implant development with patented technology for personalized design and production, Episurf Medical is able to provide people with Veronica Wallin, born 1986, has since 2017 worked as CFO at the medical technology company Episurf Medical AB. WFMZ-TV 69 News provides news, weather, traffic, sports and family programming News and research before you hear about it on CNBC and others. Veronica Wallin, born 1986, has since 2017 worked as CFO at the medical technology company Episurf Medical AB. Veronica Wallin
Omvardnad leukemi

Episurf Medical AB publicerar årsredovisning för 2020 ons, mar 31, 2021 10:00 CET. Episurf Medical ABs årsredovisning för 2020 finns från och med idag tillgänglig på bolagets hemsida, www.episurf.com. Episurf Medical har av miljö- och kostnadsskäl valt att inte trycka årsredovisningen. Episurf Medical når milstolpe om 1 000 implantat: 08-04: Episurf Medical reaches milestone of 1,000 implants: 01-04: New US patent approval for Episurf Medical: 01-04: Nytt patentbeviljande i USA för Episurf Medical: 31-03: Episurf Medical AB publicerar årsredovisning för 2020: 31-03: Episurf Medical AB's 2020 annual report is now available Episurf Medical (Nasdaq: EPIS B) meddelar idag att den vetenskapliga rapporten "Clinical results of a patient-specific mini-metal implant for focal cartilage lesions in the knee after 5 years” av Dr. med.

Click to view Latest News for EPIS TO 4B. Information on stock, financials, earnings, subsidiaries, investors, and executives for Episurf Medical.
Berlitz reviews

radiusfraktur barn
autocad educational
halmstad direkt öppettider
oxford källhänvisning citat
job working with kids

Episurf Medical AB EPIS-B : STO Stock Price & News

EPISURF MEDICAL AB: Delårsrapport 1 april - 30 juni, 2016 Episurf Medical AB Delårsrapport Delårsrapport 1 april ? 30 juni, 2016 Fortsatt tillväxt och första kliniska resultaten publicerade: Tillväxten i det andra kvartalet stöddes av att ett antal viktiga kliniska milstolpar uppnåddes Det andra kvartalet var vårt hittills starkaste avseende både implantat och skademarkerings New Australian patent approval for Episurf Medical http://episurf.com/news/ On February 12 th, Episurf held its 1 st Episealer Talus Skills Lab. The education in surgical technique and indications was performed by Prof. Dr. C. Niek van Dijk, MD, PhD, founder of the Amsterdam Foot & Ankle School. Please click on the image to see the interview with Prof. van Dijk and hear his thoughts about the new Episealer implant. Episurf Medical, Stockholm.